Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
4.1. Human Samples
4.2. Mice
4.3. Endothelial Cells Isolation and RNA Sequencing Analysis
4.4. Immunofluorescent Staining and Histological Assessment
4.5. RNA Isolation and Quantitative Real-Time Polymerase Chain Reaction (QRT-PCR) Analysis
4.6. Western Blot Analysis
4.7. Statistical Analysis
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Simonneau, G.; Montani, D.; Celermajer, D.S.; Denton, C.P.; Gatzoulis, M.A.; Krowka, M.; Williams, P.G.; Souza, R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur. Respir. J. 2019, 53. [Google Scholar] [CrossRef]
- Humbert, M.; Guignabert, C.; Bonnet, S.; Dorfmüller, P.; Klinger, J.R.; Nicolls, M.R.; Olschewski, A.J.; Pullamsetti, S.S.; Schermuly, R.T.; Stenmark, K.R.; et al. Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives. Eur. Respir. J. 2019, 53. [Google Scholar] [CrossRef] [Green Version]
- Masri, F.A.; Xu, W.; Comhair, S.A.A.; Asosingh, K.; Koo, M.; Vasanji, A.; Drazba, J.; Anand-Apte, B.; Erzurum, S.C. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007, 293, 548–554. [Google Scholar] [CrossRef] [Green Version]
- Tu, L.; Dewachter, L.; Gore, B.; Fadel, E.; Dartevelle, P.; Simonneau, G.; Humbert, M.; Eddahibi, S.; Guignabert, C. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 2011, 45, 311–322. [Google Scholar] [CrossRef] [PubMed]
- Le Hiress, M.; Tu, L.; Ricard, N.; Phan, C.; Thuillet, R.; Fadel, E.; Dorfmüller, P.; Montani, D.; de Man, F.; Humbert, M.; et al. Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor/CD74 complex. Am. J. Respir. Crit. Care Med. 2015, 192, 983–997. [Google Scholar] [CrossRef] [PubMed]
- Evans, C.E.; Cober, N.D.; Dai, Z.; Stewart, D.J.; Zhao, Y.-Y. Endothelial cells in the pathogenesis of pulmonary arterial hypertension. Eur. Respir. J. 2021, 2003957. [Google Scholar] [CrossRef]
- Dai, Z.; Li, M.; Wharton, J.; Zhu, M.M.; Zhao, Y.-Y. Prolyl-4 hydroxylase 2 (PHD2) Deficiency in endothelial cells and hematopoietic cells induces obliterative vascular remodeling and severe pulmonary arterial hypertension in mice and humans through hypoxia-inducible factor-2α. Circulation 2016, 133, 2447–2458. [Google Scholar] [CrossRef] [Green Version]
- Dai, Z.; Zhao, Y.Y. Discovery of a murine model of clinical PAH: Mission impossible? Trends Cardiovasc. Med. 2017, 27, 229–236. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dai, Z.; Zhu, M.M.; Peng, Y.; Jin, H.; Machireddy, N.; Qian, Z.; Zhang, X.; Zhao, Y.-Y. Endothelial and smooth muscle cell interaction via FoxM1 signaling mediates vascular remodeling and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 2018, 198, 788–802. [Google Scholar] [CrossRef]
- Wierstra, I. The transcription factor FOXM1 (Forkhead box M1). In Advances in Cancer Research; Elsevier Inc.: Amsterdam, The Netherlands, 2013; Volume 118, pp. 97–398. ISBN 9780124071735. [Google Scholar]
- Zhao, Y.Y.; Gao, X.P.; Zhao, Y.D.; Mirza, M.K.; Frey, R.S.; Kalinichenko, V.V.; Wang, I.C.; Costa, R.H.; Malik, A.B. Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J. Clin. Investig. 2006, 116, 2333–2343. [Google Scholar] [CrossRef] [Green Version]
- Mirza, M.K.; Sun, Y.; Zhao, Y.D.; Potula, H.H.S.K.; Frey, R.S.; Vogel, S.M.; Malik, A.B.; Zhao, Y.Y. FoxM1 regulates re-annealing of endothelial adherens junctions through transcriptional control of β-catenin expression. J. Exp. Med. 2010, 207, 1675–1685. [Google Scholar] [CrossRef]
- Rhodes, C.J.; Im, H.; Cao, A.; Hennigs, J.K.; Wang, L.; Sa, S.; Chen, P.I.; Nickel, N.P.; Miyagawa, K.; Hopper, R.K.; et al. RNA sequencing analysis detection of a novel pathway of endothelial dysfunction in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 2015, 192, 356–366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wilson, J.L.; Wang, L.; Zhang, Z.; Hill, N.S.; Polgar, P. Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension. PLoS ONE 2019, 14, e0221728. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bourgeois, A.; Lambert, C.; Habbout, K.; Ranchoux, B.; Paquet-Marceau, S.; Trinh, I.; Breuils-Bonnet, S.; Paradis, R.; Nadeau, V.; Paulin, R.; et al. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension. J. Mol. Med. 2018, 96, 223–235. [Google Scholar] [CrossRef] [PubMed]
- Dai, J.; Zhou, Q.; Tang, H.; Chen, T.; Li, J.; Raychaudhuri, P.; Yuan, J.X.J.; Zhou, G. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension. Cell. Signal. 2018, 51, 119–129. [Google Scholar] [CrossRef] [PubMed]
- Uhlén, M.; Fagerberg, L.; Hallström, B.M.; Lindskog, C.; Oksvold, P.; Mardinoglu, A.; Sivertsson, Å.; Kampf, C.; Sjöstedt, E.; Asplund, A.; et al. Tissue-based map of the human proteome. Science 2015, 347. [Google Scholar] [CrossRef] [PubMed]
- Yuan, K.; Liu, Y.; Zhang, Y.; Nathan, A.; Tian, W.; Yu, J.; Sweatt, A.J.; Shamshou, E.A.; Condon, D.; Chakraborty, A.; et al. Mural cell SDF1 signaling is associated with the pathogenesis of pulmonary arterial hypertension. Am. J. Respir. Cell Mol. Biol. 2020, 62, 747–759. [Google Scholar] [CrossRef]
- Bordenave, J.; Thuillet, R.; Tu, L.; Phan, C.; Cumont, A.; Marsol, C.; Huertas, A.; Savale, L.; Hibert, M.; Galzi, J.L.; et al. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Cardiovasc. Res. 2020, 116, 686–697. [Google Scholar] [CrossRef]
- Bordenave, J.; Tu, L.; Berrebeh, N.; Thuillet, R.; Cumont, A.; Le Vely, B.; Fadel, E.; Nadaud, S.; Savale, L.; Humbert, M.; et al. Lineage tracing reveals the dynamic contribution of pericytes to the blood vessel remodeling in pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 2020, 766–782. [Google Scholar] [CrossRef] [PubMed]
- Huang, X.; Dai, Z.; Cai, L.; Sun, K.; Cho, J.; Albertine, K.H.; Malik, A.B.; Schraufnagel, D.E.; Zhao, Y.Y. Endothelial p110γPI3K mediates endothelial regeneration and vascular repair after inflammatory vascular injury. Circulation 2016, 133, 1093–1103. [Google Scholar] [CrossRef] [Green Version]
- Cavallero, S.; Shen, H.; Yi, C.; Lien, C.L.; Kumar, S.R.; Sucov, H.M. CXCL12 Signaling is essential for maturation of the ventricular coronary endothelial Plexus and establishment of functional coronary circulation. Dev. Cell 2015, 33, 469–477. [Google Scholar] [CrossRef] [Green Version]
- Ivins, S.; Chappell, J.; Vernay, B.; Suntharalingham, J.; Martineau, A.; Mohun, T.J.; Scambler, P.J. The CXCL12/CXCR4 Axis plays a critical role in coronary artery development. Dev. Cell 2015, 33, 455–468. [Google Scholar] [CrossRef] [Green Version]
- Pitt, L.A.; Tikhonova, A.N.; Hu, H.; Trimarchi, T.; King, B.; Gong, Y.; Sanchez-Martin, M.; Tsirigos, A.; Littman, D.R.; Ferrando, A.A.; et al. CXCL12-producing vascular endothelial niches control acute T Cell Leukemia maintenance. Cancer Cell 2015, 27, 755–768. [Google Scholar] [CrossRef] [Green Version]
- Maan, Z.N.; Hu, M.S.; Rennert, R.; Barrera, J.A.; Duscher, D.; Januszyk, M.; Whittam, A.; Padmanabhan, J.; Vial, N.; Ho, N.; et al. Endothelial CXCL12 regulates neovascularization during tissue repair and tumor progression. bioRxiv 2020, 13, vzj2013.08.0148. [Google Scholar] [CrossRef]
- Döring, Y.; Van Der Vorst, E.P.C.; Duchene, J.; Jansen, Y.; Gencer, S.; Bidzhekov, K.; Atzler, D.; Santovito, D.; Rader, D.J.; Saleheen, D.; et al. CXCL12 Derived from endothelial cells promotes atherosclerosis to drive coronary artery disease. Circulation 2019, 139, 1338–1340. [Google Scholar] [CrossRef] [PubMed]
- McCullagh, B.N.; Costello, C.M.; Li, L.; O’Connell, C.; Codd, M.; Lawrie, A.; Morton, A.; Kiely, D.G.; Condliffe, R.; Elliot, C.; et al. Elevated plasma CXCL12α is associated with α poorer prognosis in pulmonary arterial hypertension. PLoS ONE 2015, 10, e0123709. [Google Scholar] [CrossRef] [PubMed]
- Young, K.C.; Torres, E.; Hatzistergos, K.E.; Hehre, D.; Suguihara, C.; Hare, J.M. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ. Res. 2009, 104, 1293–1301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Farkas, D.; Kraskauskas, D.; Drake, J.I.; Alhussaini, A.A.; Kraskauskiene, V.; Bogaard, H.J.; Cool, C.D.; Voelkel, N.F.; Farkas, L. CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of c-kit+ cells in rats. PLoS ONE 2014, 9, e89810. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Provencher, S.; Archer, S.L.; Ramirez, F.D.; Hibbert, B.; Paulin, R.; Boucherat, O.; Lacasse, Y.; Bonnet, S. Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research. Circ. Res. 2018, 122, 1021–1032. [Google Scholar] [CrossRef] [PubMed]
- Kim, I.M.; Ramakrishna, S.; Gusarova, G.A.; Yoder, H.M.; Costa, R.H.; Kalinichenko, V.V. The Forkhead Box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J. Biol. Chem. 2005, 280, 22278–22286. [Google Scholar] [CrossRef] [Green Version]
- Song, S.; Zhang, R.; Cao, W.; Fang, G.; Yu, Y.; Wan, Y.; Wang, C.; Li, Y.; Wang, Q. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter. J. Cell. Physiol. 2019, 234, 9052–9064. [Google Scholar] [CrossRef] [Green Version]
- Tang, H.; Babicheva, A.; McDermott, K.M.; Gu, Y.; Ayon, R.J.; Song, S.; Wang, Z.Z.; Gupta, A.; Zhou, T.; Sun, X.; et al. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am. J. Physiol. Lung Cell. Mol. Physiol. 2018, 314, L256–L275. [Google Scholar] [CrossRef]
- Van Der Feen, D.E.; Kurakula, K.; Tremblay, E.; Boucherat, O.; Bossers, G.P.L.; Szulcek, R.; Bourgeois, A.; Lampron, M.C.; Habbout, K.; Martineau, S.; et al. Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 2019, 200, 910–920. [Google Scholar] [CrossRef] [PubMed]
- Dai, Z.; Zhu, M.M.; Peng, Y.; Machireddy, N.; Evans, C.E.; Machado, R.; Zhang, X.; Zhao, Y.-Y. Therapeutic targeting of vascular remodeling and right heart failure in pulmonary arterial hypertension with a HIF-2α inhibitor. Am. J. Respir. Crit. Care Med. 2018, 198, 1423–1434. [Google Scholar] [CrossRef] [PubMed]
- Stearman, R.S.; Bui, Q.M.; Speyer, G.; Handen, A.; Cornelius, A.R.; Graham, B.B.; Kim, S.; Mickler, E.A.; Tuder, R.M.; Chan, S.Y.; et al. Systems analysis of the human pulmonary arterial hypertension lung transcriptome. Am. J. Respir. Cell Mol. Biol. 2019, 60, 637–649. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Sathiyamoorthy, K.; Zhang, X.; Schaller, S.; Perez White, B.E.; Jardetzky, T.S.; Longnecker, R. Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus. Nat. Microbiol. 2018, 3, 172–180. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yi, D.; Liu, B.; Wang, T.; Liao, Q.; Zhu, M.M.; Zhao, Y.-Y.; Dai, Z. Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension. Int. J. Mol. Sci. 2021, 22, 3182. https://doi.org/10.3390/ijms22063182
Yi D, Liu B, Wang T, Liao Q, Zhu MM, Zhao Y-Y, Dai Z. Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 2021; 22(6):3182. https://doi.org/10.3390/ijms22063182
Chicago/Turabian StyleYi, Dan, Bin Liu, Ting Wang, Qi Liao, Maggie M. Zhu, You-Yang Zhao, and Zhiyu Dai. 2021. "Endothelial Autocrine Signaling through CXCL12/CXCR4/FoxM1 Axis Contributes to Severe Pulmonary Arterial Hypertension" International Journal of Molecular Sciences 22, no. 6: 3182. https://doi.org/10.3390/ijms22063182